{
    "nct_id": "NCT03845660",
    "official_title": "The REVeAL-HF Trial: Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure",
    "inclusion_criteria": "* Age >18\n* NTproBNP levels of >500pg/mL within 24 hours of admission\n* Intravenous diuretics within 24 hours of admission\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "â€¢ None",
    "miscellaneous_criteria": ""
}